Merganser Biotech
King Of Prussia, US · Delaware corporation · 1 known investors
Founders & leadership
BM
Brian MacDonaldExecutive
RS
Remy SukhijaExecutive
Board
JT
MG
Markus GoebelBoard director
JB
Jeffrey BirdBoard director
CG
Colin GoddardBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.1M disclosed across 1 round · 2015
▶$13.1MraisedApr 2016 · 24 investors · BiotechnologyRule 506(b)
▶$13.1MraisedApr 2016 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James TopperDirector
- Colin GoddardDirector
- Markus GoebelDirector
- Brian MacDonaldExecutive Officer, Director
- Remy SukhijaExecutive Officer
- Jeffrey BirdDirector
- Offering amount
- $17.1M
- Amount sold
- $13.1M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Merganser Biotech's investors?
- Merganser Biotech's investors include Frazier Life Sciences.
- How much funding has Merganser Biotech raised?
- Merganser Biotech has disclosed $13.1M raised across 1 round.
- Where is Merganser Biotech headquartered?
- Merganser Biotech is headquartered in King Of Prussia, US.